Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A T Profy

Showing results (21-30 of 25) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 25 results.
Science (New York, N.Y.)|February 15, 1991
Conserved sequence and structural elements in the HIV-1 principal neutralizing determinant: corrections and clarificationsG J LaRosa, J P Davide, K Weinhold, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 1, 1989
Principal neutralizing domain of the human immunodeficiency virus type 1 envelope proteinK Javaherian, A J Langlois, C McDanal, et al.
The Journal of Biological Chemistry|January 24, 1998
Conformational integrity and ligand binding properties of a single chain T-cell receptor expressed in Escherichia coliS S Khandekar, B M Bettencourt, D F Wyss, et al.
Antimicrobial Agents and Chemotherapy|January 1, 1996
Naphthalene sulfonate polymers with CD4-blocking and anti-human immunodeficiency virus type 1 activitiesS Rusconi, M Moonis, D P Merrill, et al.
Molecular Immunology|April 1, 1997
Affinity and kinetics of the interactions between an alphabeta T-cell receptor and its superantigen and class II-MHC/peptide ligandsS S Khandekar, P P Brauer, J W Naylor, et al.
Pageof 3

Showing results (21-30 of 25) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 25 results.
Science (New York, N.Y.)|February 15, 1991
Conserved sequence and structural elements in the HIV-1 principal neutralizing determinant: corrections and clarificationsG J LaRosa, J P Davide, K Weinhold, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 1, 1989
Principal neutralizing domain of the human immunodeficiency virus type 1 envelope proteinK Javaherian, A J Langlois, C McDanal, et al.
The Journal of Biological Chemistry|January 24, 1998
Conformational integrity and ligand binding properties of a single chain T-cell receptor expressed in Escherichia coliS S Khandekar, B M Bettencourt, D F Wyss, et al.
Antimicrobial Agents and Chemotherapy|January 1, 1996
Naphthalene sulfonate polymers with CD4-blocking and anti-human immunodeficiency virus type 1 activitiesS Rusconi, M Moonis, D P Merrill, et al.
Molecular Immunology|April 1, 1997
Affinity and kinetics of the interactions between an alphabeta T-cell receptor and its superantigen and class II-MHC/peptide ligandsS S Khandekar, P P Brauer, J W Naylor, et al.
Pageof 3